SFX by Ex Libris Inc.

Title:	Structural assets of a tumor suppressor
Source:	Science [0036-8075] Tonks, N K yr:2000

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Di Cristofano, A. "The multiple roles of PTEN in tumor suppression." Cell 100.4 (2000): 387-90.
description	2.	McCombie, R. "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer." Science 275.5308 (1997): 1943-7.
description	3.	Cantley, L C C. "New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway." Proceedings of the National Academy of Sciences of the United States of America 96.8 (1999): 4240-4245.
description	4.	Ho, A. "Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes." Current opinion in genetics & development 12.1 (2002): 47-52.
description	5.	Simpson, L. "PTEN: life as a tumor suppressor." Experimental cell research 264.1 (2001): 29-41.
description	6.	Yilmaz, S. "Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells." Nature 441.7092 (2006): 475-482.
description	7.	Steck, P. "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers." Nature genetics 15.4 (1997): 356-62.
description	8.	Zhang, J. "PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention." Nature 441.7092: 518-522.
description	9.	Stambolic, V. "Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN." Cell 95.1 (1998): 29-39.
description	10.	Tamura, M. "Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN." Science 280.5369 (1998): 1614-7.
description	11.	Maehama, T. "The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate." The Journal of biological chemistry 273.22 (1998): 13375-8.
description	12.	Sherr, Charles J. J. "A New Cell-Cycle Target in Cancer — Inhibiting Cyclin D–Dependent Kinases 4 and 6." The New England Journal of Medicine 375.20 (2016): 1920-1923.
description	13.	Carracedo, A. "Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer." The journal of clinical investigation 118.9 (2008): 3065-74.
description	14.	Chen, Y N N. "Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists." Proceedings of the National Academy of Sciences of the United States of America 96.8 (1999): 4325-9.
description	15.	Dahia, P L L. "PTEN, a unique tumor suppressor gene." Endocrine-related cancer 7.2 (2000): 115-29.
description	16.	Rossi, Derrick J J. "Pten, tumorigenesis, and stem cell self-renewal." Cell 125.2 (2006): 229-31.
description	17.	Hede, K. "PTEN takes center stage in cancer stem cell research, works as tumor suppressor." Journal of the National Cancer Institute 98.12 (2006): 808-809.
description	18.	Dirks, Sheila K B. "Identification of human brain tumour initiating cells." Nature 432.7015 (2004): 396-401.
description	19.	Scadden, V. "Stem cells: good, bad and reformable." Nature 441.7092 (2006): 418-419.
description	20.	Cantley, Lewis C C. "The phosphoinositide 3-kinase pathway." Science 296.5573 (2002): 1655-7.